US Patent Issued to MABCARE THERAPEUTICS on Jan. 27 for "Anti-PTK7 antibody and uses thereof" (Chinese Inventor)

ALEXANDRIA, Va., Jan. 28 -- United States Patent no. 12,534,541, issued on Jan. 27, was assigned to MABCARE THERAPEUTICS (Shanghai).

"Anti-PTK7 antibody and uses thereof" was invented by Tao Meng (Shanghai).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to anti-PTK7 antibodies or antigen-binding fragments thereof, nucleic acid molecules encoding the same, and use thereof in preparation of antibody-drug conjugates, and further relates to antibody-drug conjugates containing the antibodies or antigen-binding fragments thereof and preparation method and use thereof."

The patent was filed on Feb. 14, 2025, under Application No. 19/053,626.

*For further information, including images...